Search research articles
Contact Us
Filters
Showing results (31-40 of 159) with videos related to
Page
of 16
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
February 9, 2011
Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer
David J Sher, Jon O Wee, Rinaa S Punglia
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 27, 2014
Value considerations in the treatment of head and neck cancer: radiation, chemotherapy, and supportive care
Shrujal S Baxi, David J Sher, David G Pfister
International Journal of Radiation Oncology, Biology, Physics
|
April 2, 2014
Prevalence and predictors of neoadjuvant therapy for stage IIIA non-small cell lung cancer in the National Cancer Database: importance of socioeconomic status and treating institution
David J Sher, Michael J Liptay, Mary Jo Fidler
International Journal of Radiation Oncology, Biology, Physics
|
February 1, 2015
Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer
Matthew Koshy, Renuka Malik, Ralph R Weichselbaum, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 12, 2015
Comparative effectiveness of neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery for patients with stage IIIA non-small cell lung cancer
David J Sher, Mary Jo Fidler, Michael J Liptay, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 15, 2015
Stereotactic body radiotherapy and treatment at a high volume facility is associated with improved survival in patients with inoperable stage I non-small cell lung cancer
Matthew Koshy, Renuka Malik, Usama Mahmood, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 21, 2011
Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis
David J Sher, Bridget A Neville, Aileen B Chen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 9, 2007
Quantification of mediastinal and hilar lymph node movement using four-dimensional computed tomography scan: implications for radiation treatment planning
David J Sher, John A Wolfgang, Andrzej Niemierko, et al.
Cancer
|
April 3, 2014
Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base
David J Sher, Matthew Koshy, Michael J Liptay, et al.
Practical Radiation Oncology
|
September 29, 2015
Comparative effectiveness of aggressive thoracic radiation therapy and concurrent chemoradiation therapy in metastatic lung cancer
Matthew Koshy, Renuka Malik, Usama Mahmood, et al.
Page
of 16
Search research articles
Search
Showing results (31-40 of 159) with videos related to
Sort By:
Page
of 16
International Journal of Radiation Oncology, Biology, Physics
|
February 9, 2011
Cost-effectiveness analysis of stereotactic body radiotherapy and radiofrequency ablation for medically inoperable, early-stage non-small cell lung cancer
David J Sher, Jon O Wee, Rinaa S Punglia
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
May 27, 2014
Value considerations in the treatment of head and neck cancer: radiation, chemotherapy, and supportive care
Shrujal S Baxi, David J Sher, David G Pfister
International Journal of Radiation Oncology, Biology, Physics
|
April 2, 2014
Prevalence and predictors of neoadjuvant therapy for stage IIIA non-small cell lung cancer in the National Cancer Database: importance of socioeconomic status and treating institution
David J Sher, Michael J Liptay, Mary Jo Fidler
International Journal of Radiation Oncology, Biology, Physics
|
February 1, 2015
Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer
Matthew Koshy, Renuka Malik, Ralph R Weichselbaum, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 12, 2015
Comparative effectiveness of neoadjuvant chemoradiotherapy versus chemotherapy alone followed by surgery for patients with stage IIIA non-small cell lung cancer
David J Sher, Mary Jo Fidler, Michael J Liptay, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
January 15, 2015
Stereotactic body radiotherapy and treatment at a high volume facility is associated with improved survival in patients with inoperable stage I non-small cell lung cancer
Matthew Koshy, Renuka Malik, Usama Mahmood, et al.
International Journal of Radiation Oncology, Biology, Physics
|
May 21, 2011
Predictors of IMRT and conformal radiotherapy use in head and neck squamous cell carcinoma: a SEER-Medicare analysis
David J Sher, Bridget A Neville, Aileen B Chen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 9, 2007
Quantification of mediastinal and hilar lymph node movement using four-dimensional computed tomography scan: implications for radiation treatment planning
David J Sher, John A Wolfgang, Andrzej Niemierko, et al.
Cancer
|
April 3, 2014
Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base
David J Sher, Matthew Koshy, Michael J Liptay, et al.
Practical Radiation Oncology
|
September 29, 2015
Comparative effectiveness of aggressive thoracic radiation therapy and concurrent chemoradiation therapy in metastatic lung cancer
Matthew Koshy, Renuka Malik, Usama Mahmood, et al.
Page
of 16